Pancreatic Anastomosis — MCQs

10 questions

According to endoscopic ultrasound (EUS) criteria for chronic pancreatitis, the main pancreatic duct is considered dilated when its diameter is:

Which of the following is the LEAST likely indication for surgical intervention in pancreatic ascites?

Liver transplant for which of the following conditions will require a duct-to-jejunal anastomosis rather than a duct-to-duct anastomosis?

Tumour of the uncinate process of the pancreas will compress which artery

Which finding best predicts poor outcome in acute pancreatitis at admission?

Patients with chronic pancreatitis often exhibit a "chain of lakes" appearance in ERCP examinations. Management is?

All of the following form posterior relations of the head of the pancreas, except.

What is the treatment of choice in a patient with Crohn’s disease, where inflamed appendix was found on exploration?

After pancreaticoduodenectomy (PD surgery), when should the first postoperative follow-up visit be scheduled to assess the patient's recovery?

Q10

What is the median survival time for patients with carcinoma of the pancreas after surgery and adjuvant therapy?

Pancreatic Anastomosis Indian Medical PG Practice Questions and MCQs

Question 1: According to endoscopic ultrasound (EUS) criteria for chronic pancreatitis, the main pancreatic duct is considered dilated when its diameter is:

A. >1 mm
B. >2 mm
C. 1.5 mm
D. >3 mm (Correct Answer)

Explanation: A main pancreatic duct diameter **greater than 3 mm** is a significant endoscopic ultrasound (EUS) criterion for the diagnosis of **chronic pancreatitis**. This dilation indicates advanced disease and is often accompanied by other EUS features like **lobularity**, **hyperechoic foci/stranding**, and cysts. While a dilated pancreatic duct is indicative of chronic pancreatitis, a diameter of **>1 mm** is generally too small to be considered a definitive EUS criterion for significant disease. A main pancreatic duct diameter greater than 2 mm is often considered abnormal [1], but it's **not the established threshold** used in EUS criteria for chronic pancreatitis. A diameter of 1.5 mm is usually considered within the **normal range** for the main pancreatic duct in many clinical contexts.

Question 2: Which of the following is the LEAST likely indication for surgical intervention in pancreatic ascites?

A. Persistent symptoms despite conservative management (Correct Answer)
B. Recurrent ascites with significant symptoms
C. Failure of medical management
D. Leak from the stented duct

Explanation: ***Persistent symptoms despite conservative management*** - This is the **LEAST likely indication** because it is vague and non-specific compared to the other options - Conservative management for pancreatic ascites (including bowel rest, TPN, somatostatin analogues) typically requires **4-6 weeks to assess efficacy** - "Persistent symptoms" alone does not constitute a surgical indication unless accompanied by **specific complications** or **documented failure** of conservative therapy - Surgery is considered only after clear evidence of treatment failure, not merely symptom persistence during the trial period *Recurrent ascites with significant symptoms* - **Recurrence of ascites** after initial control indicates failure of conservative or endoscopic management - Significant symptoms (abdominal distension, pain, respiratory compromise, malnutrition) with recurrence are a **strong indication for surgical intervention** - Suggests underlying pancreatic duct disruption that requires definitive surgical repair *Failure of medical management* - **Clear failure of medical management** is a **primary indication for surgery** in pancreatic ascites - Includes failure to control ascites with octreotide, TPN, repeated paracentesis, and bowel rest - Indicates need for surgical approaches such as internal drainage, resection, or duct repair *Leak from the stented duct* - A **leak from a stented pancreatic duct** represents **failure of endoscopic therapy** - This is a **direct and specific indication** for surgical intervention - Ongoing pancreatic fluid leakage despite stenting requires surgical repair to prevent complications such as infection, malnutrition, and persistent fluid collections

Question 3: Liver transplant for which of the following conditions will require a duct-to-jejunal anastomosis rather than a duct-to-duct anastomosis?

A. Alagille syndrome
B. Liver cirrhosis
C. Primary biliary cholangitis
D. Primary sclerosing cholangitis (Correct Answer)

Explanation: ***Primary sclerosing cholangitis*** - **Primary sclerosing cholangitis (PSC)** is characterized by **inflammation and scarring of the bile ducts**, leading to strictures and impaired bile flow. - Due to the widespread nature of the disease and the potential for residual diseased ducts in the recipient, a **duct-to-jejunal anastomosis (Roux-en-Y hepaticojejunostomy)** is preferred to ensure optimal drainage and avoid complications like cholangitis and anastomotic strictures at the native duct. *Alagille syndrome* - **Alagille syndrome** is a genetic disorder causing **bile duct paucity and cholestasis**. - While it affects the bile ducts, the native large bile duct in the recipient is often suitable for a **duct-to-duct anastomosis** without significant risk of recurrent disease-related strictures. *Liver cirrhosis* - **Cirrhosis** from most causes (e.g., viral hepatitis, alcohol) primarily affects the **liver parenchyma**, not the bile ducts directly. - In such cases, the native bile duct is usually healthy, allowing for a straightforward **duct-to-duct anastomosis**. *Primary biliary cholangitis* - **Primary biliary cholangitis (PBC)** is an autoimmune disease primarily affecting the **small intrahepatic bile ducts**. - The larger extrahepatic bile ducts are typically spared and healthy, making a **duct-to-duct anastomosis** the standard and preferred method for bile drainage after transplant.

Question 4: Tumour of the uncinate process of the pancreas will compress which artery

A. Superior mesenteric artery (Correct Answer)
B. Inferior mesenteric artery
C. Common hepatic artery
D. Splenic artery

Explanation: ***Superior mesenteric artery*** - The **uncinate process** forms the lower and medial part of the head of the pancreas, hooking around and behind the **superior mesenteric vessels**. - A tumor in this region would therefore almost immediately compress the **superior mesenteric artery** and vein due to its close anatomical relationship. *Splenic artery* - The **splenic artery** runs along the superior border of the pancreas, primarily associated with the body and tail. - A tumor in the **uncinate process** (part of the head) would be anatomically distant from the splenic artery, making compression unlikely. *Inferior mesenteric artery* - The **inferior mesenteric artery** arises from the aorta much lower than the pancreas, typically at the L3 vertebral level. - Its anatomical position makes it spatially separated from the uncinate process of the pancreas, so compression is not expected. *Common hepatic artery* - The **common hepatic artery** runs anterior to the portal vein and to the left of the bile duct, supplying the liver. - It is located superior to the head of the pancreas and away from the uncinate process, hence not typically affected by tumors in that specific pancreatic region.

Question 5: Which finding best predicts poor outcome in acute pancreatitis at admission?

A. Ranson score >3 (Correct Answer)
B. Serum lipase >1000
C. Blood glucose >200
D. Pleural effusion

Explanation: ***Ranson score >3*** - A **Ranson score** greater than 3 on admission is a strong predictor of **severe acute pancreatitis** and increased **mortality** [1]. - The Ranson criteria assess multiple parameters, including age, WBC count, LDH, AST, and glucose, providing a comprehensive risk assessment [1]. *Serum lipase >1000* - An elevated **serum lipase level** is highly diagnostic of acute pancreatitis but does not directly correlate with disease severity or prognosis. - While reflecting pancreatic inflammation, lipase levels often do not predict the development of **organ failure** or **necrotizing pancreatitis** [1]. *Blood glucose >200* - **Hyperglycemia** at admission is one of the Ranson criteria, but as a single parameter, it is not as strong a predictor of poor outcome as the complete score. - Isolated high glucose can be due to stress or pre-existing **diabetes**, contributing to some severity but not sufficient for widespread poor prognosis without other factors. *Pleural effusion* - **Pleural effusion** can be a complication of severe pancreatitis, indicating surrounding inflammation. - However, its presence at admission, without other markers of severity, is less predictive of overall poor outcome than a validated scoring system like the Ranson score which assesses multiple systemic factors.

Question 6: Patients with chronic pancreatitis often exhibit a "chain of lakes" appearance in ERCP examinations. Management is?

A. Total pancreatectomy
B. Resecting the tail of pancreas and performing a pancreaticojejunostomy
C. Sphincteroplasty
D. Side to side pancreaticojejunostomy (Correct Answer)

Explanation: ***Side to side pancreaticojejunostomy*** - This procedure, specifically a **Puestow procedure**, is the gold standard for managing painful chronic pancreatitis with a dilated main pancreatic duct (≥6-7 mm) and multiple strictures, presenting as a "chain of lakes" on ERCP. - It involves dividing the small bowel, closing one end, and connecting the other to a longitudinal incision made along the dilated pancreatic duct, thereby allowing drainage of pancreatic secretions into the jejunum and alleviating pain. *Total pancreatectomy* - This is a highly morbid procedure reserved for very severe cases of chronic pancreatitis that are refractory to other treatments, often associated with unmanageable pain and severe exocrine and endocrine insufficiency. - It would necessitate lifelong **enzyme replacement therapy** and **insulin for diabetes**, indicating its use as a last resort. *Sphincteroplasty* - This procedure involves widening the sphincter of Oddi and is primarily used for **biliary obstruction** or **pancreatitis secondary to sphincter dysfunction**, not for the widespread strictures and dilated ducts typical of chronic pancreatitis with a "chain of lakes" appearance. - While it can improve drainage, it does not address the extensive ductal pathology seen in many cases of chronic pancreatitis with multiple strictures. *Resecting the tail of pancreas and performing a pancreaticojejunostomy* - This describes a **distal pancreatectomy with pancreaticojejunostomy**, which is suitable for lesions or pathologies primarily confined to the **body or tail of the pancreas**, such as certain tumors or cysts. - It would not effectively address the diffuse ductal changes and multiple strictures throughout the entire pancreas that cause the "chain of lakes" appearance in chronic pancreatitis, which usually requires decompression of the entire duct system.

Question 7: All of the following form posterior relations of the head of the pancreas, except.

A. Common Bile Duct
B. Inferior Vena cava
C. First part of duodenum (Correct Answer)
D. Aorta

Explanation: ***First part of Duodenum*** - The **first part of the duodenum** is an **anterior relation** to the head of the pancreas, not a posterior one. - It curves around the head of the pancreas superiorly and anteriorly. *Common Bile Duct* - The **common bile duct** passes **posterior** to the head of the pancreas before entering the duodenum. - It lies in a groove on the posterior surface or can even be embedded within the pancreatic head. *Aorta* - The **aorta** is a major vessel situated **posterior** to the head of the pancreas. - Specifically, the **abdominal aorta** lies behind the uncinate process and the head of the pancreas. *Inferior Vena Cava* - The **inferior vena cava (IVC)** runs **posterior** to the head of the pancreas. - This major vein is a key posterior relation, often lying to the right of the aorta.

Question 8: What is the treatment of choice in a patient with Crohn’s disease, where inflamed appendix was found on exploration?

A. Appendectomy
B. Closing the abdomen and starting medical treatment
C. Right hemicolectomy
D. Ileo–colic resection and anastomosis (Correct Answer)

Explanation: ***Ileo-colic resection and anastomosis*** - This is the treatment of choice when an inflamed appendix is found during exploration in a patient with Crohn's disease, as the disease typically affects the **terminal ileum** and **right colon**. - The inflamed appendix is often a manifestation of Crohn's disease involving the **cecal base** and surrounding bowel. - **Ileo-colic resection** ensures removal of the diseased segment, including the inflamed appendix and involved bowel, thereby preventing future complications such as **fistulas** (risk up to 65% with simple appendectomy) and **strictures**. - If the cecal base is involved with Crohn's disease, simple appendectomy is contraindicated due to poor healing and high fistula risk. *Appendectomy* - Performing a simple appendectomy in the context of Crohn's disease carries a high risk of **fistula formation** and **poor wound healing** due to the underlying inflammatory process. - When the disease involves the **base of the appendix** and surrounding **cecum** (which is common), appendectomy alone is insufficient and dangerous. - Appendectomy may only be considered safe if the cecal base is completely **normal and uninvolved**, which is uncommon in this clinical scenario. *Closing the abdomen and starting medical treatment* - While medical treatment is crucial for managing Crohn's disease, an **inflamed appendix** found during exploration suggests an acute process that requires **surgical intervention**. - Delaying surgery by closing the abdomen could lead to complications such as **perforation** and **peritonitis**, especially if inflammation is severe. - Medical therapy alone is insufficient for acute complications requiring exploration. *Right hemicolectomy* - Right hemicolectomy is a more extensive resection than necessary for most cases of ileocecal Crohn's disease with appendiceal involvement. - **Ileo-colic resection** (removing terminal ileum, cecum, and ascending colon up to the hepatic flexure) is adequate and preferred as it is less extensive while addressing the pathology. - Right hemicolectomy would be reserved for more extensive colonic involvement beyond the typical ileocecal distribution.

Question 9: After pancreaticoduodenectomy (PD surgery), when should the first postoperative follow-up visit be scheduled to assess the patient's recovery?

A. 3 weeks
B. 4 weeks
C. 1 week
D. 2 weeks (Correct Answer)

Explanation: ***2 weeks*** - A 2-week recall after **pancreaticoduodenectomy (PD surgery)** allows sufficient time for early postoperative complications to manifest while still being within a window for timely intervention. - This timeframe enables assessment of **wound healing**, resolution of ileus, nutritional status, and early recognition of issues like **pancreatic fistula** or **delayed gastric emptying**. *1 week* - A 1-week recall might be too early to identify some significant complications that typically present slightly later, such as **pancreatic fistula**. - At this stage, patients are often still in the acute recovery phase, making comprehensive outpatient assessment less informative. *3 weeks* - Delaying recall until 3 weeks might be too late for optimal management of certain **postoperative complications**, potentially leading to more severe outcomes. - Early symptoms of complications could be missed, increasing the risk of re-admission or prolonged recovery. *4 weeks* - By 4 weeks, many **early complications** that require timely intervention may have become more advanced or difficult to manage. - This recall period is often used for a more routine follow-up rather than immediate assessment of acute recovery.

Question 10: What is the median survival time for patients with carcinoma of the pancreas after surgery and adjuvant therapy?

A. Approximately 12 months
B. Approximately 32 months
C. Approximately 22 months (Correct Answer)
D. Approximately 44 months

Explanation: ***Approximately 22 months*** - The median survival for patients with **resectable pancreatic adenocarcinoma** treated with surgery (typically pancreaticoduodenectomy) and adjuvant chemotherapy is approximately **22-28 months** based on contemporary studies. - The 22-month figure represents a well-established median from multiple clinical trials including **ESPAC-1 and CONKO-001**, making it the most representative answer among the options provided. - This outcome reflects significant improvement from the pre-adjuvant therapy era but still underscores the aggressive biology of pancreatic cancer. *Approximately 12 months* - This figure represents **historical median survival** prior to the routine use of effective adjuvant chemotherapy, or survival in patients with **unresectable locally advanced disease** treated with palliative chemotherapy alone. - It is **not representative** of outcomes in patients who undergo complete surgical resection followed by modern adjuvant therapy. *Approximately 32 months* - While highly selected patients with **favorable tumor biology** (small tumors, negative margins, low CA 19-9) and optimal response to modern regimens like **FOLFIRINOX** may approach this survival, it exceeds the **median survival** for the general population of resected patients. - This represents the upper quartile rather than the median outcome. *Approximately 44 months* - This exceptionally long survival is **not achieved** as a median in pancreatic ductal adenocarcinoma, even with optimal surgical resection and adjuvant therapy. - Such prolonged survival is occasionally seen in **highly selected patients** or with less aggressive pancreatic neoplasms (e.g., neuroendocrine tumors, intraductal papillary mucinous neoplasms with invasive component), which have substantially better prognoses than typical ductal adenocarcinoma.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free